Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The study aims to compare the effect of intravitreal non steroidal anti inflammatory
(Diclofenac) versus the standard treatment of diabetic macular edema, intravitreal anti
vascular endothelial growth factor (Ranibizumab), measuring central macular thickness changes
and best corrected visual acuity.